Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Mar;10(3):1339-1342.
doi: 10.21037/jtd.2018.03.36.

Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?

Affiliations
Editorial

Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?

Lorraine D Cornwell et al. J Thorac Dis. 2018 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Dr. Cornwell receives research funding from the Department of Veteran Affairs Cooperative Studies Program at the Michael E. DeBakey VA Medical Center in support of the VALOR trial. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Videtic GM, Donington J, Giuliani M, et al. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 2017;7:295-301. 10.1016/j.prro.2017.04.014 - DOI - PubMed
    1. Schneider BJ, Daly ME, Kennedy EB, et al. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. J Clin Oncol 2018;36:710-9. 10.1200/JCO.2017.74.9671 - DOI - PubMed
    1. Haque W, Szeja S, Tann A, et al. Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis. Am J Clin Oncol 2018;41:259-66. - PubMed
    1. Timmerman RD, Hu C, Michalski J, et al. Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer. International Journal of Radiation Oncology 2014;90:S30 10.1016/j.ijrobp.2014.05.135 - DOI
    1. Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015;16:630-7. 10.1016/S1470-2045(15)70168-3 - DOI - PMC - PubMed

LinkOut - more resources